2025.11.18
Graph's Cytodata 2025 poster: "Decoding the functional and molecular niche of
immune-mediated disease for iterative target discovery"
Check out Graph's Cytodata 2025 poster at the link above
2025.10.07
Graph Therapeutics and Botnar Institute of Immune Engineering announce strategic
collaboration to advance precision immunology
Collaboration combines Graph's AI-driven precision immunology platform with BIIE's immune engineering
and modeling expertise to accelerate medicine development
2025.04.22
Graph Therapeutics awarded Deep Tech Life Science Seed Financing Grant from the
Austrian Wirtschaftsservice worth €1.1M
Graph has recieved the deep tech life sciences seed program grant from the funding from the Austria
Wirtschaftsservice (AWS) to advance our clinically realistic precision immunology platform.
2025.03.28
Graph co-founder Berend Snijder appointed as Faculty Professor at the Botnar
Institute of Immune Engineering
The Snijder lab specializes in systems oncology and immunology research. His group at the BIIE will
continue to bridge biology with machine learning methods to further our understanding of molecular
systems for medicine.
2025.01.09
Graph Therapeutics Raises $3.1M Pre-Seed Round to Transform Drug Discovery for
Immunological Diseases
Veteran techbio team that pioneered AI-driven precision oncology reunites to tackle the critical and
complex challenges of inflammatory and immunological diseases
